Peripheral targets of 5-HT1D receptor immunoreactive trigeminal ganglion neurons

Headache

Volumn 51, Issue 5, 2011, Pages 744-751

  Ivanusic, Jason J ^a   Kwok, Matthew M K ^a   Jennings, Ernest A ^a,b  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b JAMES COOK UNIVERSITY   (Australia)

Author keywords

5 hydroxy triptamine1D; neurovascular; primary headache; trigeminal; triptan

Indexed keywords

SEROTONIN 1D RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; IMMUNOCOMPETENT CELL; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LACRIMAL GLAND; MALE; MENINGEAL ARTERY; MIDDLE CEREBRAL ARTERY; MOUSE; NONHUMAN; NOSE MUCOSA; PRIORITY JOURNAL; SENSORY NERVE; TRIGEMINUS GANGLION;

ANIMALS; IMMUNOHISTOCHEMISTRY; LACRIMAL APPARATUS; MALE; MIDDLE CEREBRAL ARTERY; NASAL MUCOSA; NEURONS, AFFERENT; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, SEROTONIN, 5-HT1D; TRIGEMINAL GANGLION;

EID: 79955470922     PISSN: 00178748     EISSN: 15264610     Source Type: Journal    
DOI: 10.1111/j.1526-4610.2011.01862.x     Document Type: Article

References (30)

1. Arulmozhi DK, Veeranjaneyulu A, Bodhankar SL,. Migraine: Current concepts and emerging therapies. Vascul Pharmacol. 2005; 43: 176-187. (Pubitemid 41160471)
2. Edvinsson L, Uddman R,. Neurobiology in primary headaches. Brain Res Brain Res Rev. 2005; 48: 438-456. (Pubitemid 40731510)
3. Launer LJ, Terwindt GM, Ferrari MD,. The prevalence and characteristics of migraine in a population-based cohort: The GEM study. Neurology. 1999; 53: 537-542. (Pubitemid 29382048)
4. Leroux E, Ducros A,. Cluster headache. Orphanet J Rare Dis. 2008; 3: 20.
5. Brennan KC, Charles A,. An update on the blood vessel in migraine. Curr Opin Neurol. 2010; 23: 266-274.
6. Goadsby PJ,. Pathophysiology of cluster headache: A trigeminal autonomic cephalgia. Lancet Neurol. 2002; 1: 251-257. (Pubitemid 37159187)
7. Goadsby PJ, Charbit AR, Andreou AP, Akerman S, Holland PR,. Neurobiology of migraine. Neurosci. 2009; 161: 327-341.
8. Olesen J, Burstein R, Ashina M, Tfelt-Hansen P,. Origin of pain in migraine: Evidence for peripheral sensitisation. Lancet Neurol. 2009; 8: 679-690.
9. Ahn AH, Basbaum AI,. Where do triptans act in the treatment of migraine? Pain. 2005; 115: 1-4.
10. Ekbom K,. Treatment of cluster headache: Clinical trials, design and results. Cephalalgia. 1995; 15 (Suppl. 15): 33-36.
11. Ferrari MD, Goadsby PJ, Roon KI, Lipton RB,. Triptans (serotonin, 5-HT1B/1D agonists) in migraine: Detailed results and methods of a meta-analysis of 53 trials. Cephalalgia. 2002; 22: 633-658. (Pubitemid 36609333)
12. Goadsby PJ,. New targets in the acute treatment of headache. Curr Opin Neurol. 2005; 18: 283-288. (Pubitemid 40813756)
13. Gobel H, Lindner V, Heinze A, Ribbat M, Deuschl G,. Acute therapy for cluster headache with sumatriptan: Findings of a one-year long-term study. Neurology. 1998; 51: 908-911. (Pubitemid 28449291)
14. Bonaventure P, Voorn P, Luyten WH, Leysen JE,. 5HT1B and 5HT1D receptor mRNA differential co-localization with peptide mRNA in the guinea pig trigeminal ganglion. Neuroreport. 1998; 9: 641-645. (Pubitemid 28131278)
15. Hou M, Kanje M, Longmore J, Tajti J, Uddman R, Edvinsson L,. 5-HT(1B) and 5-HT(1D) receptors in the human trigeminal ganglion: Co-localization with calcitonin gene-related peptide, substance P and nitric oxide synthase. Brain Res. 2001; 909: 112-120. (Pubitemid 32710124)
16. Longmore J, Shaw D, Smith D, et al,. Differential distribution of 5HT1D- and 5HT1B-immunoreactivity within the human trigemino-cerebrovascular system: Implications for the discovery of new antimigraine drugs. Cephalalgia. 1997; 17: 833-842.
17. Potrebic S, Ahn AH, Skinner K, Fields HL, Basbaum AI,. Peptidergic nociceptors of both trigeminal and dorsal root ganglia express serotonin 1D receptors: Implications for the selective antimigraine action of triptans. J Neurosci. 2003; 23: 10988-10997. (Pubitemid 37499709)
18. Harriott AM, Gold MS,. Serotonin type 1D receptors (5HTR) are differentially distributed in nerve fibres innervating craniofacial tissues. Cephalalgia. 2008; 28: 933-944.
19. Ivanusic JJ, Kwok MM, Ahn AH, Jennings EA,. 5-HT1D receptor immunoreactivity in the sphenopalatine ganglion: Implications for the efficacy of triptans in the treatment of autonomic signs associated with cluster headache. Headache. 2011; 51: 392-402.
20. O'Connor TP, van der Kooy D,. Pattern of intracranial and extracranial projections of trigeminal ganglion cells. J Neurosci. 1986; 6: 2200-2207. (Pubitemid 16043662)
21. Strassman AM, Weissner W, Williams M, Ali S, Levy D,. Axon diameters and intradural trajectories of the dural innervation in the rat. J Comp Neurol. 2004; 473: 364-376. (Pubitemid 38580456)
22. Ma QP, Hill R, Sirinathsinghji D,. Colocalization of CGRP with 5-HT1B/1D receptors and substance P in trigeminal ganglion neurons in rats. Eur J Neurosci. 2001; 13: 2099-2104. (Pubitemid 32578795)
23. Strassman AM, Levy D,. The anti-migraine agent sumatriptan induces a calcium-dependent discharge in meningeal sensory neurons. Neuroreport. 2004; 15: 1409-1412. (Pubitemid 38925232)
24. Jennings EA, Ryan RM, Christie MJ,. Effects of sumatriptan on rat medullary dorsal horn neurons. Pain. 2004; 111: 30-37. (Pubitemid 39141004)
25. Goadsby PJ, Edvinsson L, Ekman R,. Vasoactive peptide release in the extracerebral circulation of humans during migraine headache. Ann Neurol. 1990; 28: 183-187. (Pubitemid 20244522)
26. Moskowitz MA,. Neurogenic versus vascular mechanisms of sumatriptan and ergot alkaloids in migraine. Trends Pharmacol Sci. 1992; 13: 307-311.
27. Ahn AN,. On the temporal relationship between throbbing migraine pain and arterial pulse. Headache. 2010; 50: 1507-1510.
28. Jeong HJ, Chenu D, Johnson EE, Connor M, Vaughan CW,. Sumatriptan inhibits synaptic transmission in the rat midbrain periaqueductal grey. Mol Pain. 2008; 4: 54.
29. Bingham S, Davey PT, Sammons M, Raval P, Overend P, Parsons AA,. Inhibition of inflammation-induced thermal hypersensitivity by sumatriptan through activation of 5-HT1B/1D receptors. Exp Neurol. 2001; 167: 65-73. (Pubitemid 32066410)
30. Nikai T, Basbaum AI, Ahn AH,. Profound reduction of somatic and visceral pain in mice by intrathecal administration of the anti-migraine drug, sumatriptan. Pain. 2008; 139: 533-540.